Skip to content
gadodiamide hydrate

Structure via PubChem · Public domain (PubChem)

EntityQ2031078· pop 9· linked from 65 articles

gadodiamide hydrate

Sign in to save

Also known as GDDTPA-BMA, Omniscan, Gadolinium [bis(2-{(carboxylatomethyl)[2-(methylamino)-2-oxoethyl]amino}ethyl)amino]acetate--water (1/1), Gadodiamidum, Gadolinium 5,8-bis(carboxylatomethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oate hydrate, Gadodiamida, S-041

Gadodiamide, sold under the brand name Omniscan, is a gadolinium-based MRI contrast agent (GBCA), used in magnetic resonance imaging (MRI) procedures to assist in the visualization of blood vessels.

Chemical data

Formula
C16H28GdN5O9
Molecular weight
591.67 g/mol
IUPAC name
2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate;gadolinium(3+);hydrate
SMILES
CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
InChIKey
XPCLDSMKWNNKOM-UHFFFAOYSA-K
Polar surface area
189 Ų
H-bond donors
3
H-bond acceptors
12
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
1993
Admin. routes
parenteral

via ChEMBL · EBI

Wikidata facts

Mass
592.113
Has use
medication
Show 6 more facts
chemical formula
C₁₆H₂₈GdN₅O₉
World Health Organisation international non-proprietary name
gadodiamide
canonical SMILES
CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
subject has role
contrast agent
route of administration
intravenous infusion and defusion
legal status (medicine)
boxed warning
Sources (5)

via Wikidata · CC0

~3 min read

Encyclopedic overview

5 sections
Contents
  • Medical uses
  • Adverse effects
  • Hypersensitivity and anaphylaxis
  • Society and culture
  • References

Gadodiamide, sold under the brand name Omniscan, is a gadolinium-based MRI contrast agent (GBCA), used in magnetic resonance imaging (MRI) procedures to assist in the visualization of blood vessels.

== Medical uses ==

Excerpted from Wikipedia’s “gadodiamide hydrate” article, available under the CC BY-SA 4.0 licence.

Available in 9 languages

via Wikidata sitelinks · CC0